加米霉素，CAS 登记号 145435-72-9，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 加米霉素 的 CAS 号：145435-72-9，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Gamithromycin · CAS 145435-72-9 · C40H76N2O12. UNII ZE856183S0.
| CAS Registry Number | 145435-72-9 |
|---|---|
| PubChem CID | 59364992 |
| Molecular formula | C40H76N2O12 |
| IUPAC name | (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one |
| UNII (FDA) | ZE856183S0 |
| Molecular Weight | 777.0 |
|---|---|
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 9 |
| Exact Mass | 776.53982586 |
| Monoisotopic Mass | 776.53982586 |
| Topological Polar Surface Area | 180 |
| Heavy Atom Count | 54 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%), H361 (93.2%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
Gamithromycin; 145435-72-9; gamitromicina; gamithromycinum; ML-1709460; ML-460; ML-1,709,460; ZE856183S0; DTXSID90904260; RefChem:57021; DTXCID501478285; Zactran; MFCD09954125; Gamithromycin [USAN:INN]; UNII-ZE856183S0; C40H76N2O12
CAS 145435-72-9; molecular formula C40H76N2O12; molecular weight — g/mol.
Gamithromycin, 145435-72-9, gamitromicina, gamithromycinum, ML-1709460, ML-460.
Hazard statements reported: H315, H319, H361.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.